Comprehensive Analysis of Transcriptomic Profiles Identified the Prediction of Prognosis and Drug Sensitivity of Aminopeptidase-Like 1 (NPEPL1) for Clear Cell Renal Cell Carcinoma

Table 1

Association between NPEPL1 expression and various clinicopathological characteristics in the TCGA database.

Characteristic		Low expression of NPEPL1	High expression of NPEPL1
		N = 269	N = 270
Age, mean ± SD		61.09 ± 12.04	60.16 ± 12.15
Gender, n (%)	Female	91 (16.9%)	95 (17.6%)
	Male	178 (33%)	175 (32.5%)
Histologic grade, n (%)	G1	7 (1.3%)	7 (1.3%)
	G2	135 (25.4%)	100 (18.8%)
	G3	97 (18.3%)	110 (20.7%)
	G4	24 (4.5%)	51 (9.6%)
Pathologic stage, n (%)	Stage I	164 (30.6%)	108 (20.1%)
	Stage II	28 (5.2%)	31 (5.8%)
	Stage III	46 (8.6%)	77 (14.4%)
	Stage IV	30 (5.6%)	52 (9.7%)
T stage, n (%)	T1	166 (30.8%)	112 (20.8%)
	T2	34 (6.3%)	37 (6.9%)
	T3	66 (12.2%)	113 (21%)
	T4	3 (0.6%)	8 (1.5%)
N stage, n (%)	N0	126 (49%)	115 (44.7%)
	N1	6 (2.3%)	10 (3.9%)
M stage, n (%)	M0	236 (46.6%)	192 (37.9%)
	M1	28 (5.5%)	50 (9.9%)